M&A
confidence high
sentiment neutral
materiality 0.78
BeyondSpring Inc. (BYSI): M&A transaction — BeyondSpring closes first tranche of SEED Therapeutics stake sale for $7.4M; total deal $35.4M
BeyondSpring Inc.
- First closing transferred 1,730,454 SEED Series A-1 Preferred Shares for $7,354,433 cash.
- Amendment added 230,400 shares to Winning View for $979,203; total purchase price unchanged at ~$35.4M.
- BYSI ownership in SEED fell from 46.87% to 40.12%; control retained until second closing expected by Dec 2025.
- Pro forma gain on disposition of SEED estimated at $67.5M; SEED classified as discontinued operations.
- Remaining 6,603,183 shares to be sold in two closings through 2026; no assurance of completion.